Skip to content
Home/Companies/HealthTech/Jeisys
Jeisys

Jeisys

HealthTech·South Korea·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Jeisys?

Jeisys is a HealthTech company based in South Korea, currently owned by ARCHIMED since 2024 and NiXEN.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
ARCHIMED
Most recent investor
ARCHIMED
MED Rise · 2024 · Buyout
2 ownership periods · full history below

Key facts

HQSouth Korea
SectorHealthTech
Websitejeisys.com

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by NiXEN and ARCHIMED since 2023.
Co-invest · 2 holders · 2023 · present
NiXEN
NiXENActive
2023 · present(3yr) · NiXEN II · 2012 · Buyout
ARCHIMED
ARCHIMEDActive
2024 · present(2yr) · MED Rise · 2024 · Buyout

More from MED Rise

Other portfolio companies in the same fund.

IRAB
IRAB
Active
PharmaSpain· 2026
Renata Medical
Active
MedTechUnited States· 2026
Agatha
Active
HealthTechJapan· 2025
Arkstone
Active
HealthTechUS· 2025
Ceva
Ceva
Active
PharmaFrance· 2025
Ceva Animal Health
Ceva Animal Health
Active
PharmaFrance· 2025

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Jeisys?

Jeisys is currently owned by ARCHIMED and NiXEN, through MED Rise, since 2024.

When did ARCHIMED and 1 other acquire Jeisys?

ARCHIMED and 1 other acquired Jeisys in 2024.

Who has owned Jeisys over time?

Jeisys has been through 2 private-equity ownership periods: NiXEN · via NiXEN II · since 2023; ARCHIMED · via MED Rise · since 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue